Rankings
▼
Calendar
NIVF
NewGenIvf Group Limited
$13980
Q4 2023 Earnings
Healthcare
Medical - Healthcare Plans
Income Statement
Revenue
$2M
Gross Profit
$196,825
13.0% margin
Operating Income
-$1M
-83.3% margin
Net Income
-$955,000
-62.9% margin
EPS (Diluted)
$165.25
QoQ Revenue Growth
+Infinity%
Cash Flow
Operating Cash Flow
-$142,705
Free Cash Flow
-$142,709
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$4M
Total Liabilities
$1M
Stockholders' Equity
$16M
Cash & Equivalents
$54,104
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$2M
$0
—
Gross Profit
$196,825
$0
—
Operating Income
-$1M
-$115,638
-994.8%
Net Income
-$955,000
$474,362
-301.3%
← FY 2023
All Quarters
Q3 2024 →
NIVF Q4 2023 Earnings — NewGenIvf Group Limited Revenue & Financial Results | Market Cap Arena